Moneycontrol PRO
HomeNewsOpinionWhy the market has brushed aside the Russian vaccine launch

Why the market has brushed aside the Russian vaccine launch

The Russian vaccine is seen more as a boost for Putin than for immunity, especially as it still has to pass Phase 3 trials

August 13, 2020 / 10:19 IST
Representative image
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts